A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 4,500 Estimated
- Expected completion
- Aug 2032
- Record updated
- Sep 22, 2026
- Lead sponsor
- Eli Lilly and Company